Background. This prospective study was designed to test the hypothesis that the assessment of left ventricular systolic function at the time of emergency room (ER) presentation provides valuable diagnostic and prognostic information in patients with cardiac-related symptoms.
C linical and electrocardiographic (ECG) var- iables are routinely used for evaluating patients presenting to the emergency room (ER) with cardiac-related symptoms.1-12 Whereas such information has both diagnostic and prognostic information, the benefits of evaluating left ventricular systolic function in the ER are unknown. We hypothesized that the assessment of left ventricular systolic function at the time of ER presentation would provide diagnostic and prognostic information above and beyond that available from the historical, clinical, and ECG data. In this study, left ventricular systolic function was assessed using two-dimensional echocardiography (2DE), and the relation between left ventricular systolic function and cardiac events that occur during or soon after presentation to the ER versus those that occur later are described.
Methods Patient Sample
One hundred eighty-five consecutive patients who presented to the University of Virginia Medical
Center ER with cardiac-related symptoms and who met the inclusion criteria were prospectively enrolled in this study. Among this group there were 202 ER visits. In the 14 patients with repeat ER visits, the first was used as the index visit. Men and women were considered eligible for the study if they were older than 30 and 40 years, respectively, and if the symptoms included chest pain or shortness of breath that lasted for at least 30 minutes within 4 hours of ER presentation. Subjects were not eligible for the study if symptoms could be explained by noncardiac causes, local trauma, or preexisting abnormalities on chest x-ray such as skeletal or pulmonary pathology.
Protocol
The protocol was approved by the Human Investigation Committee of the University of Virginia School of Medicine. All patients entered in the study gave informed consent. At the time of presentation to the ER, a member of the study team obtained a detailed history and performed a complete physical examination. In addition, a 12-lead electrocardiogram and serum enzyme measurements were obtained, and 2DE was performed.
All but one member of the study team had completed 3 years of internal medicine residency and all but one had at least 3 months of training in 2DE. A member of the study team was on call for the study 24 hours a day. The information obtained on 2DE was not divulged to the ER physician, who made the patient disposition based entirely on historical, clinical, and ECG data.
Variables Analyzed
The historical information used to evaluate the patients in this report included age, sex, and a history of hypertension and cigarette smoking. The clinical data included the presence of jugular venous distension, third heart sound, and pulmonary rales. Three observers blinded to the historical and clinical data evaluated the electrocardiograms and 2DE on separate occasions.
The electrocardiogram was classified as either normal or abnormal. An abnormal electrocardiogram was characterized as having one or more of the following specific abnormalities: ST elevation or depression more than 1.0 mm (without or with Q waves), Q waves without ST or T wave changes, T wave inversion more than 1.0 mm, nonspecific ST or T wave changes, left ventricular hypertrophy, left or right bundle branch block, and paced rhythm. 13 The 2DE variables that were analyzed included left and right ventricular and left atrial sizes and left ventricular systolic function.14 For assessment of the latter, the left ventricle was divided into 12 segments (Figure 1) normal or abnormal systolic function and assigning a wall motion score. Abnormal systolic function was considered to be present in a segment if it manifested both abnormal motion and thickening. Based on the degree of systolic dysfunction, the following scores were also assigned to each segment: 1 for normal systolic function; 2 for hypokinesia; 3 for akinesia; and 4 for dyskinesia. 15 The scores for each segment were then added to determine the total left ventricular wall motion score. In this manner, a left ventricle showing normal systolic function would be assigned a wall motion score of 12. The worse the function, the higher would be the score.
Patient Follow-up Follow-up was obtained over a 2-year period by contacting the patient, the patient's family and physician, and by monitoring the hospital admissions. Study end points included cardiac-related death, nonfatal myocardial infarction confirmed by new Q waves or cardiac enzyme changes,'3'16"17 life-threatening arrhythmias requiring medical or surgical intervention, and intractable angina pectoris requiring revascularization (either coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty). Events that occurred within 48 hours of ER presentation were defined as early events. Late events included those that occurred after 48 hours of ER presentation.
Statistical Methods
Since the exact time of onset of early cardiac events could not be precisely ascertained within the 48-hour period, logistic regression models were used to evaluate the association between early outcomes and each ER finding.'8 Use of the logistic models was further supported by the completeness of patient follow-up during this brief period. Analysis for late events was based on proportional hazards regression models,19 since event times and lengths of follow-up could be easily distinguished among the study participants. All models were evaluated for fit, and the results suggested that they To further explore the independent effect of LVSD, the value of the ER findings for determining late and early events was evaluated in terms of their additive importance in the order in which they would normally be observed. The process began by examining the information from age alone, followed by the added contribution from the historical and clinical data, followed by the additional value of the electrocardiogram, and finally, by the additive information provided by 2DE. Tests of significance were based on increases in the likelihood ratio statistic due to the sequentially added information.23 For practical purposes, the percent change in the likelihood ratio statistic relates directly to the percent change in the overall prognostic power. All differences were considered significant at p<0.05 and all tests of significance were two sided. Results Of the 185 patients originally entered into the study, 12 were excluded from analysis because of technically inadequate 2DE studies and two were 'excluded because of a complete loss to follow-up. Among the remaining 171 patients who are described in this report, there were 88 men and 83 women with average ages of 59±14 and 62±14 years, respectively.
All Events Table 1 presents the rates of early and late cardiac events stratified by the type of event. In the 171 patients, 55 (32%) had adverse cardiac events within the 2-year follow-up period: 32 had events within 48 hours of ER presentation and 23 had events after 48 hours of ER presentation. Early events were largely composed of nonfatal myocardial infarctions (29 of 32). There were no deaths and no revascularization procedures. Three subjects with early events experienced life-threatening arrhythmias (ventricular tachycardia, complete heart block, and Mobitz type II block, respectively). Among the 23 late events, the incidence rates of nonfatal myocardial infarction (11) and death (10) were similar; two patients underwent revascularization for intractable angina, and there were no reports of arrhythmias. Table 2 presents the age-adjusted rates of events occurring within 48 hours of ER presentation. There were no significant correlates of early cardiac events among the historical and clinical findings. An abnormal electrocardiogram was associated with a more than threefold excess of early events (p<0.05). Subjects with ST elevation had a sixfold excess of early events as compared to those without this finding (p<0.001). The presence of LVSD was the only 2DE finding that had a significant positive association with early cardiac events.
Early Events
There was more than an eightfold excess of early events among patients who presented in the ER with this finding (p<0.01). Among the patients without ST elevation, an age-adjusted sixfold excess of early events was observed in the presence of LVSD as compared to its absence (20.5% versus 3.4%,p<0.01).
Late Events Table 3 provides the age-adjusted rates of events occurring after 48 hours of ER presentation. Among the historical data, subjects with a history of hypertension had a ninefold excess of cardiac events as compared to those without such a history (p<0.001). Jugular venous distension on physical examination was associated with more than a fourfold excess of cardiac events (p<0.001), whereas a threefold excess was observed in those with a third heart sound (p<0.01).
Patients with an abnormal electrocardiogram experienced late cardiac events at a rate nearly three times higher than those with a normal electrocardiogram (p<0.05). Patients with ECG evidence of left ventric- 
Independent Effect of LVSD
In Table 4 , age-adjusted rates of various findings are given for subjects without and with LVSD. Patients with the latter finding were significantly more likely to have a third heart sound (p<O.O1) and pulmonary rales (p<0.05). An abnormal electrocardiogram (p<O.OO1), ST elevation (p<O.OO1), and left bundle branch block (p<O.O1) also occurred with greater frequency in the presence of LVSD. Patients with LVSD were also more likely to have enlargement of the left and right ventricles (p<O0.01) and the left atrium (p<O.001) on 2DE.
Based on the associations among the ER findings and each cardiac event, the independent effect of LVSD on early and late outcomes was examined after adjusting for selected data. For early events, the most important confounders of LVSD included age and an abnormal electrocardiogram. After adjustment for these factors, the association between LVSD and early cardiac events was diminished slightly, but remained highly significant (p<O.O1) (Figure 2A ). Figure 2B illustrates the relation between early events and the degree of LVSD, as exemplified by the left ventricular wall motion score. Whereas the event rate increased significantly in patients with a wall motion score of 13-24 compared to those with a score of 12, a further increase in events was not noted in patients with a score of more than 24. The results did not change appreciably after adjusting for age and presence of abnormal electrocardiogram.
or events that occurred after 48 hours of ER presentation, the most important confounders affecting the relation between LVSD and late cardiac outcomes included age and a history of hypertension. After adjusting for these factors, 91.5% of those with normal ventricular systolic function were free of a cardiac event at the end of 2 years of follow-up as compared to 72.6% of those who exhibited LVSD (p<O.O1). Unadjusted and adjusted event-free survival based on the presence or absence of LVSD is depicted in Figure 3 . Figure 4A illustrates unadjusted late event-free survival based on the degree of LVSD as exemplified by the left ventricular wall motion score. The higher the observed score, the greater seems the likelihood of suffering an adverse cardiac event. When eventfree survival in these patients with late events was adjusted for the confounding effects of age and hypertension, event rates among subjects with different degrees of LVSD became similar ( Figure 4B ), although differences between those with and without LVSD continued to remain highly significant (p<O.Ol). Figure 5 . For early events ( Figure 5A ), 
Discussion
Our results indicate that one third of all patients presenting to the ER with symptoms suggestive of cardiac etiology suffered a major cardiac event within the ensuing two years. In addition, for those with normal left ventricular systolic function, less than 10% had cardiac events. In those with LVSD, nearly half suffered an event. Only one patient with normal left ventricular systolic function and a normal electrocardiogram had an event in the 2-year follow-up period. Regardless of the time an event was observed, the direct assessment of left ventricular function in the ER added significantly to the diagnostic and prognostic value of age and the historical, clinical, and ECG findings. These results imply that, in addition to routine clinical and ECG evaluation, left ventricular systolic function should also be assessed in patients presenting to the ER with cardiac-related symptoms. Of identical concern are the patients in whom events occurred after 48 hours of ER presentation. Among the 139 subjects not experiencing early events, 23 (17%) had adverse outcomes in the two-year follow-up. Unlike those experiencing events within 48 hours, these patients were as likely to die as they were to suffer a nonfatal infarction. In addition, the historical and clinical profiles of these patients were different from those suffering early events. Victims of late events were more likely to have a history of hypertension and signs of congestive heart failure, such as jugular venous distension and a third heart sound. Apart from an increased incidence of left ventricular hypertrophy, the other ECG abnormalities in such patients were nonspecific. Despite the presence of congestive heart failure, which is a known prognosticator of adverse outcomes, LVSD on 2DE provided significant additional prognostic information in these patients. The results were similar for the patients who died and those who suffered an ischemic event (nonfatal infarction or revascularization).
Unfortunately, the evaluation of patients in the ER has been largely limited to stratifying them into high-and low-risk categories for acute events. [9] [10] [11] [12] The long-term prognosis has not been evaluated in these patients. This prospectively designed study suggests that the event rate in such patients is high, and that identifying LVSD at the time of ER presentation is useful in recognizing those who are more likely to suffer an event. For instance, this finding may be a more important marker of death than clinical and ECG abnormalities in patients with myocardial disorders such as ischemic or hypertensive cardiomyopathy. Similarly, in the 13 patients who suffered an ischemic event after 48 hours of ER presentation (11 with myocardial infarction and two undergoing revascularization), the presence of LVSD at the time of the ER visit may have reflected an acute ischemic episode that preceded the actual infarction or a need for revascularization. Importance of the Degree of LVSD Whereas the presence of LVSD was important in identifying early and late events, the degree of dysfunction did not seem to be as important. Most of the early events (29 of 32) were acute myocardial infarctions. The presence of regional dyssynergy identifies the occurrence of an infarction. The number of segments exhibiting this finding does not necessarily add to the diagnosis of acute myocardial infarction. Consequently, one would not expect the degree of LVSD to be important in determining the occurrence of an infarction in these patients, although other events such as death may be related to the degree of LVSD.
In contrast to early events, one would have expected some relation between the occurrence of events and the degree of LVSD in patients experiencing late events who had clinical and other evidence of heart failure. Unadjusted event rates seem to support this expectation. When data are adjusted for the confounding effects of age and history of hypertension, however, the degree of LVSD (among those with this finding) no longer provides independent predictive power.
The reason for a loss of the prognostic power of the degree of LVSD in predicting late events once adjustment for advanced age and a history of hypertension is made is not readily apparent from our data. Among these patients, those with left ventricular wall motion score of more than 24 were significantly older (p<0.05) than those with lower wall motion scores despite having the same prevalence of hypertension. As such, controlling for age and hypertension may have been similar to controlling for duration of hypertension. As a consequence, subjects with wall motion scores of more than 24 may have been at greater risk of late events than those whose scores were lower (>12 but .24), because the higher scores may have been more often associated with older ages and a longer duration of hypertension.
Value of Other ER Findings
Although the presence or absence of LVSD was clearly related to early and late cardiac events in this patient sample, the value of routinely measured ER findings continues to be important. Our results indicate that, whereas historical and clinical data have questionable value in predicting early events, they provide important information in terms of late events. Similarly, while the electrocardiogram is very useful for predicting early events, it has lesser value for late events. The presence of LVSD, however, provides diagnostic and prognostic information for both early and late events over and above that already provided by age and the historical, clinical, and EKG data routinely observed in patients presenting to the ER with cardiac-related symptoms. Logistics of Performing 2DE in the ER Although it was not the purpose of this study to assess the logistics of performing 2DE in the ER, it may be worth discussing some of the concerns related to this issue. At the time this study was performed, there were approximately 42,000 annual visits to our ER, of whom about two thirds were nonsurgical. Of the latter group, approximately 10% constituted patients who complained of chest pain. Of these patients, no more than five or six met our inclusion criteria over a 24-hour period. Despite being on call 24 hours at a time, therefore, members of the study team did not have to perform 2DE more than five or six times a day.
To identify patients with LVSD, physicians trained in performing and interpreting 2DE studies would be required to evaluate patients presenting to the ER with cardiac-related symptoms. This service could be provided by either a cardiologist or an ER physician trained in selected aspects of 2DE. Which of these two options is more practical and cost-effective needs to be determined. It is likely that the option chosen will depend as much on local hospital based factors as on training of the individual.
Clinical Implications of Our Findings
Our results suggest that a patient presenting to the ER with cardiac-related symptoms be initially given a physical examination and an electrocardiogram. If ECG findings diagnostic for acute myocardial infarction or physical findings of congestive heart failure are absent, evaluation of left ventricular systolic function becomes valuable. In our data, patients without ST elevation or findings of congestive heart failure had a significantly increased risk of both early and late events in the presence of LVSD. As a result, it would seem prudent that subjects with LVSD in whom an acute event is suspected should be admitted to the hospital. In patients with acute symptoms, the absence of LVSD can ease the decision to discharge a patient from the ER, particularly if the electrocardiogram is also normal. Patients with LVSD not suspected to have an acute event or an acute exacerbation of a chronic condition necessitating hospital admission should be aggressively evaluated as outpatients in the very near future. Patients with LVSD on 2DE should not be lost to follow-up.
